ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats (Q46779292)

25 December 2017

title

ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats (English)

1 reference

25 December 2017

0 references

Jorge E Toblli

1

1 reference

25 December 2017

Marina C Muñoz

2

1 reference

25 December 2017

Gabriel Cao

3

1 reference

25 December 2017

José Mella

4

1 reference

25 December 2017

Lisandro Pereyra

5

1 reference

25 December 2017

Ricardo Mastai

6

1 reference

25 December 2017

language of work or name

1 reference

24 January 2007

1 reference

25 December 2017

published in

Obesity

1 reference

25 December 2017

volume

16

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

770-776

1 reference

25 December 2017

https://api.crossref.org/works/10.1038%2FOBY.2007.114

1 reference

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Steatohepatitis: a tale of two "hits"?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Liver fibrogenesis: a new role for the renin-angiotensin system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Angiotensin-converting enzyme inhibition reduces lipid deposits in myocardium and improves left ventricular function of obese zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Insulin resistance: a metabolic pathway to chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Risk reduction therapy for syndrome X: comparison of several treatments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Animal models of steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

The role of leptin in progression of non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

Leptin receptor-deficient Zucker (fa/fa) rat retards the development of pig serum-induced liver fibrosis with Kupffer cell dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.114

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.114

1 reference

25 December 2017

1 reference

25 December 2017